Camurus AB is a pharmaceutical company based in Lund, Sweden, that develops and commercialises medicines formulated to release their active ingredients slowly over time. Its products are long-acting injectable and implantable treatments built on the company's lipid-based delivery technology, and they are used in areas such as the treatment of opioid dependence and the management of pain and other chronic conditions. The company works with healthcare providers and partners to make these treatments available in markets around the world.
The shares are listed on the London Stock Exchange in UK under the code 0RD1, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1142 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
81/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average16.3%
From 52-week high-5.3%
MomentumFair
67/100
Typical recent returns for this exchange.
See the numbers →
3-month return7.1%
6-month return23.0%
12-month, skipping last month-1.0%
Stability (higher is calmer)Weak
34/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)44.3%
Worst drawdown, 1 year (smaller is calmer)-37.7%
LiquidityStrong
71/100
Trades actively.
See the numbers →
Avg daily value traded7.21M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 433.00 – 707.50Daily closes, split-adjusted
Signals
50-day average620.60
200-day average571.62
Golden/death cross (60d)Golden, 56 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)12.37
Technical summary
Daily
Strongly bullish
12 bullish · 2 neutral · 2 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
657.5
Bullish
EMA 10
658.4
Bullish
SMA 20
645.6
Bullish
EMA 20
647.4
Bullish
SMA 50
620.6
Bullish
EMA 50
627.0
Bullish
SMA 100
600.9
Bullish
EMA 100
607.2
Bullish
SMA 200
571.6
Bullish
EMA 200
595.1
Bullish
Oscillators (daily)
RSI (14)
65.88
Neutral
MACD (12, 26)
13.81
Bullish
Momentum (12)
3.38
Bullish
Stochastic %K (14)
84.00
Bearish
Williams %R (14)
-16.00
Bearish
CCI (20)
98.42
Neutral
Pivot points (classic, last session)
S3
651.0
S2
655.0
S1
660.0
Pivot
664.0
R1
669.0
R2
673.0
R3
678.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
